The first peptide for expression wrinkles

Official logo and claim of anti-wrinkle active ingredient ARGIRELINE® peptide, by Lipotec

A breakthrough in cosmetic technology as an alternative to well-known cosmetic procedures, topically targeting the same wrinkle-formation mechanism in a very different way.

  • ARGIRELINE® peptide (Acetyl Hexapeptide-8) is a replica of the N-terminal end of SNAP-25 and competes in vitro with the natural protein for a position in the SNARE complex.
  • Science. The formation of the SNARE protein complex is essential for the acetylcholine release at the synapsis, the neurotransmitter involved in muscle contraction.

Effect appears
in just 1 week

As demonstrated in vivo, a cream with 2% ARGIRELINE® peptide solution decreased appearance of wrinkles: volume diminished by 20.6% and length by 15.9%, on average, with statistically significant results. Other parameters used to describe wrinkles, like roughness and depth, were also decreased as proved in further clinical studies.

Go to product information
In vivo efficacy results showing the effect of Lipotec’s ARGIRELINE® peptide on wrinkle volume and length
In vivo efficacy results showing the effect of Lipotec’s ARGIRELINE® peptide on wrinkle volume and length

Images of the expression wrinkles of a volunteer before and after 7 days.

A recognized cosmetic solution for early fine lines

NOTIFICATION

Lipotec develops active ingredients for the personal care industry and supplies them to leading cosmetic product manufacturers and brand owners worldwide.

The information contained in Lipotec's intranet is exclusively addressed to personal care industry professionals and access to specific data will be granted according to user profile (customers, distributors, consultants, media...).

Accept